Share class: GlaxoSmithKline Pharmaceuticals Limited

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A1169,406,03441,291,265 ( 24.37 %) 0 24.37 %

Major shareholders: GlaxoSmithKline Pharmaceuticals Limited

NameStocks%Valuation
75 %
127,054,524 75 % 4 075 M ₹
Life Insurance Corporation of India (Investment Portfolio)
1.078 %
1,826,540 1.078 % 59 M ₹
Nippon Life India Asset Management Ltd. (Invt Mgmt)
1.039 %
1,759,884 1.039 % 56 M ₹
SBI Funds Management Ltd. (Investment Management)
0.9706 %
1,644,261 0.9706 % 53 M ₹
Kotak Mahindra Asset Management Co. Ltd.
0.7353 %
1,245,595 0.7353 % 40 M ₹
quant Money Managers Ltd.
0.6284 %
1,064,579 0.6284 % 34 M ₹
Government of India
0.6259 %
1,060,245 0.6259 % 34 M ₹
Aditya Birla Sun Life Insurance Co. Ltd.
0.5213 %
883,124 0.5213 % 28 M ₹
Bandhan AMC Ltd.
0.5161 %
874,370 0.5161 % 28 M ₹
Bajaj Finserv Asset Management Ltd.
0.4809 %
814,672 0.4809 % 26 M ₹
░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░

Breakdown by shareholder type

GSK Plc74.99%
Institutional7.52%
Governments0.63%
Unknown16.86%

Based on 1000 largest holdings

Geographical origin of shareholders

United Kingdom
75.19%
India
7.95%

Based on 1000 largest holdings

Logo GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited is an India-based global healthcare company. The Company is engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company has three product areas: vaccines, specialty and general medicine. Its general medicines business has a portfolio of medicines in anti-infectives, pain, vitamins medicine, nutritional, hormones, dermatologicals, respiratory and vaccines for adults and children. The Company's general medicine brands include Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, Tenovate, T-bact and Physiogel. The Company's vaccine brands include Shingrix Herpes Zoster Vaccine, Infanrix Hexa, Synflorix, Boostrix, Havrix, Menveo, Fluarix Tetra and Varilrix. Its specialty medicine brands include Nucala, Seretide, and Trelegy Ellipta. Trelegy Ellipta, single inhaler triple therapy (SITT) for chronic obstructive pulmonary disease (COPD) patients. The Subsidiary of the Company is Biddle Sawyer Limited.
Employees
3,103
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!